Should you buy KAPA stock?
Last updated:
Based on market data through , StockInvest.us rates Kairos Pharma, Ltd. (KAPA) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Down 10.26%
- 3-month trend forecast Down 37.99%
- Easy Tracking In The Watchlist
A very red day for Kairos Pharma, Ltd. stock price after a -9.33% fall in the Monday trading session
(Market data through Aug 10, 2026)
The Kairos Pharma, Ltd. stock price fell by -9.33% on the last day (Monday, 10th Aug 2026) from $0.386 to $0.350. During the last trading day the stock fluctuated 4.89% from a day low at $0.350 to a day high of $0.367. The price has risen in 6 of the last 10 days and is up by 12.98% over the past 2 weeks. Volume has increased on the last day by 862 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 862 thousand shares were bought and sold for approximately $301.77 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.99% during the next 3 months and, with a 90% probability hold a price between $0.151 and $0.237 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
KAPA Signals & Forecast
The Kairos Pharma, Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.342 and $0.346. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -10.26%. Further fall is indicated until a new bottom pivot has been found. Kairos Pharma, Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Kairos Pharma, Ltd. stock
Kairos Pharma, Ltd. finds support from accumulated volume at $0.340 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0171 between high and low, or 4.89%. For the last week, the stock has had daily average volatility of 10.75%.
Our recommended stop-loss: $0.332 (-5.04%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (KAPA) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Kairos Pharma, Ltd. to open at $0.356, and during the day (based on 14 day Average True Range), to move between $0.331 and $0.369, which gives a possible trading interval of +/-$0.0386 (+/-11.68%) up or down from last closing price. If Kairos Pharma, Ltd. takes out the full calculated possible swing range there will be an estimated 11.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.358 (2.29%) than the support at $0.340 (2.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Kairos Pharma, Ltd. stock A Buy?
Kairos Pharma, Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.356 ( 1.63%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
KAPA Performance
Trading levels for KAPA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.373 | 6.51% |
| R2 | 0.366 | 4.65% |
| R1 | 0.362 | 3.49% |
| Price | 0.350 | |
| S1 | 0.349 | -0.238% |
| S2 | 0.345 | -1.39% |
| S3 | 0.339 | -3.26% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.390 | 11.43% |
| R2 | 0.375 | 7.09% |
| R1 | 0.358 | 2.29% |
| Price | 0.350 | |
| S1 | 0.340 | -2.89% |
| S2 | 0.318 | -9.14% |
| S3 | 0.313 | -10.66% |
FAQ
Click here for our free guide on how to buy Kairos Pharma, Ltd. Stock.
Buy KAPA